Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Agfa HealthCare to Acquire European Contrast Media Company

By HospiMedica International staff writers
Posted on 21 Dec 2009
Agfa Healthcare (Mortsel, Begium) is expanding their radiology systems offering with a new range of pharmaceuticals for diagnostic imaging. More...


Agfa HealthCare, a leading provider of diagnostic imaging and healthcare information technology (IT) solutions, reported that it has signed an agreement with Curagita Holding, AG (Heidelberg, Germany) to acquire all the shares of its subsidiary Insight Agents, GmbH (Heidelberg, Germany). Insight Agents is a European developer and producer of contrast media, with business activities primarily in Germany. The final acquisition price is expected to be approximately EUR 10 million.

Contrast media are chiefly used during medical imaging examinations with X-rays, computed tomography (CT) scans, and magnetic resonance imaging (MRI), either to highlight specific anatomic structures (mostly vessels) or to perform functional imaging. Contrast media is now a multi-billion Euro market served by both large and small companies.

"The purchase of Insight Agents is an important strategic step towards future growth opportunities,” stated Christian Reinaudo, president of Agfa HealthCare. "Agfa HealthCare is a strong player in the radiology market with both Imaging and IT solutions. Today, we further enhance our diagnostic imaging business with a set of products that are increasingly used for diagnostic imaging procedures. These products are a logical addition to our portfolio of film, chemicals, and printers and will be distributed through our extensive logistics and distribution network.”

"The acquisition of Insight Agents allows us to offer to our customers a broader range of products for medical imaging,” stated Dirk Debusscher, vice president imaging at Agfa HealthCare. "Agfa HealthCare has always been a leader with its film and print solutions. The decision to purchase a new line of business was made to ensure that we continue to offer a range of diagnostic imaging products over which we have full control, enabling us to deliver the highest quality radiology solutions, on time, all of the time.”

"The comprehensive portfolio of Insight Agents fits well with the distribution and logistics expertise of Agfa HealthCare," stated Dr. Johannes Schmidt-Tophoff, CEO of Curagita Holding AG. "We are convinced that Agfa HealthCare is the perfect company to bring our expanding spectrum of contrast agents to more customers world-wide, and we are working diligently to close the transaction by the end of 2009.”

Curagita Holding is the leading independent radiology services company in Germany, managing a cooperative radiology group of 300 radiologists. The objectives of the cooperative are to save costs, to implement quality combines, and to use marketing and contracting synergies as a powerful group generating value added for referring doctors, patients, and insurances. By group purchasing of contrast agents, consumables and equipment/IT, including maintenance contracts, the costs of participating radiologists as well as of health insurances are significantly reduced.

Insight Agents develops, produces, and markets contrast media. The company headquarters is located in Germany, which is the biggest national contrast media market in Europe. Further branches of the company, which are headed by experienced industrial managers, are located in Belgium, France, UK, Italy, Austria, Switzerland, Spain, Mexico, and other countries. Insight Agents plans to extend its product range to include a full and globally marketable range of generic contrast media.

Agfa HealthCare, a member of the Agfa-Gevaert Group, is a provider of IT-enabled clinical workflow and diagnostic image management solutions, and systems for capturing and processing images in hospitals and healthcare facilities. The healthcare division has sales offices and agents in over 100 markets worldwide.

Related Links:

Agfa Healthcare
Curagita Holding
Insight Agents




Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Medical Examination & Procedure Light
Vega 80
Desk Aneroid Sphyg
Diagnostix 750D+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image Credit: 123RF

AI Platform Screens for Amyloid Cardiomyopathy Using ECG Images

Amyloid cardiomyopathy is a heart disease caused by deposits of misfolded proteins in the cardiac muscle. It is often missed until patients develop serious complications such as heart failure.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.